Global e-Clinical Trial Technologies

e-Clinical Trial Technologies Comprehensive Study by Phase (Phase I, Phase II, Phase III, Phase IV), Electronics Solutions (Clinical Analytics Platforms, Electronic Data Capture (EDC), Clinical Data Management Systems (CDMS), Randomization & Trial Supply Management (RTSM), Electronic Clinical Outcome Assessment (ECOA), Clinical Data Integration Platforms, Clinical Trial Management Systems (CTMS), Electronic Trial Master File (ETMF), Others), Offering (Solution, Services), End User (Research Organizations, Pharmaceutical Companies, Medical Device Enterprises, Others) Players and Region - Global Market Outlook to 2028

e-Clinical Trial Technologies Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 12.6%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
e-Clinical Trial Technologies Market Scope
e-Clinical is an electronic application that is used in clinical research. This is commonly used in the biopharmaceutical industry. It is a technology application used in clinical trials including IVR systems, IWR systems, and other electronic solutions. The web-based tools are major applications for e-clinical technology. The reasons behind the clinical technologies are influenced by increasing competition, high costs of drug development and others. The e-Clinical Trial Technologies market offers diverse solutions across various segments to meet the evolving needs of clinical research. Understanding these segments and their functionalities is crucial for stakeholders across the clinical trial ecosystem to select the right tools and optimize their research processes.

AttributesDetails
Study Period2018-2028
Base Year2022
High Growth MarketAsia Pacific
Largest MarketNorth America
UnitValue (USD Million)
Key Companies ProfiledBioClinica (United States), PAREXEL (United States), EClinical Solutions (India), ECRFPlus (China), Clincase (Germany), Clinical Leader (United States), Oracle (United States), Medidata Solutions (United States), Clinpal (United Kingdom), NTT DATA (Japan), DATATRAK (United States), OmniComm Systems, Inc. (United States), MedNet Solutions (United States), Prelude Dynamics (United States), Acceliant (United States), Glorant, LLC. (United States) and Medrio, Inc. (United States)
CAGR12.6%


"According to AMA, the Global e-Clinical Trial Technologies market is expected to see growth rate of 12.6% and may see market size of USD6866.12 Million by 2028."

The market is fragmented by key vendors who are focusing on production technologies, improving efficiency and shelf life. Growth opportunities can be captured by tracking the ongoing process improvement and financial flexibility to invest in optimal strategies Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global e-Clinical Trial Technologies market throughout the predicted period.

BioClinica (United States), PAREXEL (United States), EClinical Solutions (India), ECRFPlus (China), Clincase (Germany), Clinical Leader (United States), Oracle (United States), Medidata Solutions (United States), Clinpal (United Kingdom), NTT DATA (Japan), DATATRAK (United States), OmniComm Systems, Inc. (United States), MedNet Solutions (United States), Prelude Dynamics (United States), Acceliant (United States), Glorant, LLC. (United States) and Medrio, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Nextrials (United States), DSG (United States), DZS (United States) and Almac (United Kingdom).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global e-Clinical Trial Technologies market by Type and Region with country level break-up.

On the basis of geography, the market of e-Clinical Trial Technologies has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Southeast Asia, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2022. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement.

Market Leaders and their expansionary development strategies
In September 2023, Florence Healthcare, US based clinical trial service provider acquired VersaTrial to provide new e-clinical solution for research sites, CROs and sponsors. VersaTrial is smart clinical solution that has been designed to accelerate clinical research for CROs and healthcare companies.
In October 2023, Medidata (now Verista TenEleven) Decentralized Trial Platform (DTP) launched a new version of their DTP featuring enhanced patient recruitment capabilities, site integration tools, and improved remote monitoring functions.


Influencing Trend:
Increasing Demand for Real-Time Data Access and Increase Demand for EDC Solutions

Market Growth Drivers:
Rising Costs of Drug Development, Increasing Stringent Regulatory Environment Etc., Increasing Challenges in Conducting Clinical Trials for Pharmaceutical Companies and Increase Demand for Reducing IT Burden

Challenges:
Availability of a Large Number of E-clinical Solution Providers Across the Globe

Restraints:
Lack of Skilled Professionals and High Initial Capital Investment and Increasing Security and Privacy Concerns May Hamper the Growth

Opportunities:
Strong Opportunity in Emerging Countries, Due To Increasing Number of Clinical Investigators, Site Coordinators, and Medical Affairs

Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, E-Clinical Trial Technology Service Providers, Government Regulatory and Research Organizations and End-Use Industries

Report Objectives / Segmentation Covered

By Phase
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Electronics Solutions
  • Clinical Analytics Platforms
  • Electronic Data Capture (EDC)
  • Clinical Data Management Systems (CDMS)
  • Randomization & Trial Supply Management (RTSM)
  • Electronic Clinical Outcome Assessment (ECOA)
  • Clinical Data Integration Platforms
  • Clinical Trial Management Systems (CTMS)
  • Electronic Trial Master File (ETMF)
  • Others

By Offering
  • Solution
  • Services

By End User
  • Research Organizations
  • Pharmaceutical Companies
  • Medical Device Enterprises
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Costs of Drug Development
      • 3.2.2. Increasing Stringent Regulatory Environment Etc.
      • 3.2.3. Increasing Challenges in Conducting Clinical Trials for Pharmaceutical Companies
      • 3.2.4. Increase Demand for Reducing IT Burden
    • 3.3. Market Challenges
      • 3.3.1. Availability of a Large Number of E-clinical Solution Providers Across the Globe
    • 3.4. Market Trends
      • 3.4.1. Increasing Demand for Real-Time Data Access
      • 3.4.2. Increase Demand for EDC Solutions
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global e-Clinical Trial Technologies, by Phase, Electronics Solutions, Offering, End User and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global e-Clinical Trial Technologies (Value)
      • 5.2.1. Global e-Clinical Trial Technologies by: Phase (Value)
        • 5.2.1.1. Phase I
        • 5.2.1.2. Phase II
        • 5.2.1.3. Phase III
        • 5.2.1.4. Phase IV
      • 5.2.2. Global e-Clinical Trial Technologies by: Electronics Solutions (Value)
        • 5.2.2.1. Clinical Analytics Platforms
        • 5.2.2.2. Electronic Data Capture (EDC)
        • 5.2.2.3. Clinical Data Management Systems (CDMS)
        • 5.2.2.4. Randomization & Trial Supply Management (RTSM)
        • 5.2.2.5. Electronic Clinical Outcome Assessment (ECOA)
        • 5.2.2.6. Clinical Data Integration Platforms
        • 5.2.2.7. Clinical Trial Management Systems (CTMS)
        • 5.2.2.8. Electronic Trial Master File (ETMF)
        • 5.2.2.9. Others
      • 5.2.3. Global e-Clinical Trial Technologies by: Offering (Value)
        • 5.2.3.1. Solution
        • 5.2.3.2. Services
      • 5.2.4. Global e-Clinical Trial Technologies by: End User (Value)
        • 5.2.4.1. Research Organizations
        • 5.2.4.2. Pharmaceutical Companies
        • 5.2.4.3. Medical Device Enterprises
        • 5.2.4.4. Others
      • 5.2.5. Global e-Clinical Trial Technologies Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Southeast Asia
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global e-Clinical Trial Technologies (Price)
  • 6. e-Clinical Trial Technologies: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. BioClinica (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. PAREXEL (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. EClinical Solutions (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. ECRFPlus (China)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Clincase (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Clinical Leader (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Oracle (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Medidata Solutions (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Clinpal (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. NTT DATA (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. DATATRAK (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. OmniComm Systems, Inc. (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. MedNet Solutions (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Prelude Dynamics (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Acceliant (United States)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
      • 6.4.16. Glorant, LLC. (United States)
        • 6.4.16.1. Business Overview
        • 6.4.16.2. Products/Services Offerings
        • 6.4.16.3. Financial Analysis
        • 6.4.16.4. SWOT Analysis
      • 6.4.17. Medrio, Inc. (United States)
        • 6.4.17.1. Business Overview
        • 6.4.17.2. Products/Services Offerings
        • 6.4.17.3. Financial Analysis
        • 6.4.17.4. SWOT Analysis
  • 7. Global e-Clinical Trial Technologies Sale, by Phase, Electronics Solutions, Offering, End User and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global e-Clinical Trial Technologies (Value)
      • 7.2.1. Global e-Clinical Trial Technologies by: Phase (Value)
        • 7.2.1.1. Phase I
        • 7.2.1.2. Phase II
        • 7.2.1.3. Phase III
        • 7.2.1.4. Phase IV
      • 7.2.2. Global e-Clinical Trial Technologies by: Electronics Solutions (Value)
        • 7.2.2.1. Clinical Analytics Platforms
        • 7.2.2.2. Electronic Data Capture (EDC)
        • 7.2.2.3. Clinical Data Management Systems (CDMS)
        • 7.2.2.4. Randomization & Trial Supply Management (RTSM)
        • 7.2.2.5. Electronic Clinical Outcome Assessment (ECOA)
        • 7.2.2.6. Clinical Data Integration Platforms
        • 7.2.2.7. Clinical Trial Management Systems (CTMS)
        • 7.2.2.8. Electronic Trial Master File (ETMF)
        • 7.2.2.9. Others
      • 7.2.3. Global e-Clinical Trial Technologies by: Offering (Value)
        • 7.2.3.1. Solution
        • 7.2.3.2. Services
      • 7.2.4. Global e-Clinical Trial Technologies by: End User (Value)
        • 7.2.4.1. Research Organizations
        • 7.2.4.2. Pharmaceutical Companies
        • 7.2.4.3. Medical Device Enterprises
        • 7.2.4.4. Others
      • 7.2.5. Global e-Clinical Trial Technologies Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Southeast Asia
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global e-Clinical Trial Technologies (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. e-Clinical Trial Technologies: by Phase(USD Million)
  • Table 2. e-Clinical Trial Technologies Phase I , by Region USD Million (2017-2022)
  • Table 3. e-Clinical Trial Technologies Phase II , by Region USD Million (2017-2022)
  • Table 4. e-Clinical Trial Technologies Phase III , by Region USD Million (2017-2022)
  • Table 5. e-Clinical Trial Technologies Phase IV , by Region USD Million (2017-2022)
  • Table 6. e-Clinical Trial Technologies: by Electronics Solutions(USD Million)
  • Table 7. e-Clinical Trial Technologies Clinical Analytics Platforms , by Region USD Million (2017-2022)
  • Table 8. e-Clinical Trial Technologies Electronic Data Capture (EDC) , by Region USD Million (2017-2022)
  • Table 9. e-Clinical Trial Technologies Clinical Data Management Systems (CDMS) , by Region USD Million (2017-2022)
  • Table 10. e-Clinical Trial Technologies Randomization & Trial Supply Management (RTSM) , by Region USD Million (2017-2022)
  • Table 11. e-Clinical Trial Technologies Electronic Clinical Outcome Assessment (ECOA) , by Region USD Million (2017-2022)
  • Table 12. e-Clinical Trial Technologies Clinical Data Integration Platforms , by Region USD Million (2017-2022)
  • Table 13. e-Clinical Trial Technologies Clinical Trial Management Systems (CTMS) , by Region USD Million (2017-2022)
  • Table 14. e-Clinical Trial Technologies Electronic Trial Master File (ETMF) , by Region USD Million (2017-2022)
  • Table 15. e-Clinical Trial Technologies Others , by Region USD Million (2017-2022)
  • Table 16. e-Clinical Trial Technologies: by Offering(USD Million)
  • Table 17. e-Clinical Trial Technologies Solution , by Region USD Million (2017-2022)
  • Table 18. e-Clinical Trial Technologies Services , by Region USD Million (2017-2022)
  • Table 19. e-Clinical Trial Technologies: by End User(USD Million)
  • Table 20. e-Clinical Trial Technologies Research Organizations , by Region USD Million (2017-2022)
  • Table 21. e-Clinical Trial Technologies Pharmaceutical Companies , by Region USD Million (2017-2022)
  • Table 22. e-Clinical Trial Technologies Medical Device Enterprises , by Region USD Million (2017-2022)
  • Table 23. e-Clinical Trial Technologies Others , by Region USD Million (2017-2022)
  • Table 24. South America e-Clinical Trial Technologies, by Country USD Million (2017-2022)
  • Table 25. South America e-Clinical Trial Technologies, by Phase USD Million (2017-2022)
  • Table 26. South America e-Clinical Trial Technologies, by Electronics Solutions USD Million (2017-2022)
  • Table 27. South America e-Clinical Trial Technologies, by Offering USD Million (2017-2022)
  • Table 28. South America e-Clinical Trial Technologies, by End User USD Million (2017-2022)
  • Table 29. Brazil e-Clinical Trial Technologies, by Phase USD Million (2017-2022)
  • Table 30. Brazil e-Clinical Trial Technologies, by Electronics Solutions USD Million (2017-2022)
  • Table 31. Brazil e-Clinical Trial Technologies, by Offering USD Million (2017-2022)
  • Table 32. Brazil e-Clinical Trial Technologies, by End User USD Million (2017-2022)
  • Table 33. Argentina e-Clinical Trial Technologies, by Phase USD Million (2017-2022)
  • Table 34. Argentina e-Clinical Trial Technologies, by Electronics Solutions USD Million (2017-2022)
  • Table 35. Argentina e-Clinical Trial Technologies, by Offering USD Million (2017-2022)
  • Table 36. Argentina e-Clinical Trial Technologies, by End User USD Million (2017-2022)
  • Table 37. Rest of South America e-Clinical Trial Technologies, by Phase USD Million (2017-2022)
  • Table 38. Rest of South America e-Clinical Trial Technologies, by Electronics Solutions USD Million (2017-2022)
  • Table 39. Rest of South America e-Clinical Trial Technologies, by Offering USD Million (2017-2022)
  • Table 40. Rest of South America e-Clinical Trial Technologies, by End User USD Million (2017-2022)
  • Table 41. Asia Pacific e-Clinical Trial Technologies, by Country USD Million (2017-2022)
  • Table 42. Asia Pacific e-Clinical Trial Technologies, by Phase USD Million (2017-2022)
  • Table 43. Asia Pacific e-Clinical Trial Technologies, by Electronics Solutions USD Million (2017-2022)
  • Table 44. Asia Pacific e-Clinical Trial Technologies, by Offering USD Million (2017-2022)
  • Table 45. Asia Pacific e-Clinical Trial Technologies, by End User USD Million (2017-2022)
  • Table 46. China e-Clinical Trial Technologies, by Phase USD Million (2017-2022)
  • Table 47. China e-Clinical Trial Technologies, by Electronics Solutions USD Million (2017-2022)
  • Table 48. China e-Clinical Trial Technologies, by Offering USD Million (2017-2022)
  • Table 49. China e-Clinical Trial Technologies, by End User USD Million (2017-2022)
  • Table 50. Japan e-Clinical Trial Technologies, by Phase USD Million (2017-2022)
  • Table 51. Japan e-Clinical Trial Technologies, by Electronics Solutions USD Million (2017-2022)
  • Table 52. Japan e-Clinical Trial Technologies, by Offering USD Million (2017-2022)
  • Table 53. Japan e-Clinical Trial Technologies, by End User USD Million (2017-2022)
  • Table 54. India e-Clinical Trial Technologies, by Phase USD Million (2017-2022)
  • Table 55. India e-Clinical Trial Technologies, by Electronics Solutions USD Million (2017-2022)
  • Table 56. India e-Clinical Trial Technologies, by Offering USD Million (2017-2022)
  • Table 57. India e-Clinical Trial Technologies, by End User USD Million (2017-2022)
  • Table 58. South Korea e-Clinical Trial Technologies, by Phase USD Million (2017-2022)
  • Table 59. South Korea e-Clinical Trial Technologies, by Electronics Solutions USD Million (2017-2022)
  • Table 60. South Korea e-Clinical Trial Technologies, by Offering USD Million (2017-2022)
  • Table 61. South Korea e-Clinical Trial Technologies, by End User USD Million (2017-2022)
  • Table 62. Southeast Asia e-Clinical Trial Technologies, by Phase USD Million (2017-2022)
  • Table 63. Southeast Asia e-Clinical Trial Technologies, by Electronics Solutions USD Million (2017-2022)
  • Table 64. Southeast Asia e-Clinical Trial Technologies, by Offering USD Million (2017-2022)
  • Table 65. Southeast Asia e-Clinical Trial Technologies, by End User USD Million (2017-2022)
  • Table 66. Australia e-Clinical Trial Technologies, by Phase USD Million (2017-2022)
  • Table 67. Australia e-Clinical Trial Technologies, by Electronics Solutions USD Million (2017-2022)
  • Table 68. Australia e-Clinical Trial Technologies, by Offering USD Million (2017-2022)
  • Table 69. Australia e-Clinical Trial Technologies, by End User USD Million (2017-2022)
  • Table 70. Rest of Asia-Pacific e-Clinical Trial Technologies, by Phase USD Million (2017-2022)
  • Table 71. Rest of Asia-Pacific e-Clinical Trial Technologies, by Electronics Solutions USD Million (2017-2022)
  • Table 72. Rest of Asia-Pacific e-Clinical Trial Technologies, by Offering USD Million (2017-2022)
  • Table 73. Rest of Asia-Pacific e-Clinical Trial Technologies, by End User USD Million (2017-2022)
  • Table 74. Europe e-Clinical Trial Technologies, by Country USD Million (2017-2022)
  • Table 75. Europe e-Clinical Trial Technologies, by Phase USD Million (2017-2022)
  • Table 76. Europe e-Clinical Trial Technologies, by Electronics Solutions USD Million (2017-2022)
  • Table 77. Europe e-Clinical Trial Technologies, by Offering USD Million (2017-2022)
  • Table 78. Europe e-Clinical Trial Technologies, by End User USD Million (2017-2022)
  • Table 79. Germany e-Clinical Trial Technologies, by Phase USD Million (2017-2022)
  • Table 80. Germany e-Clinical Trial Technologies, by Electronics Solutions USD Million (2017-2022)
  • Table 81. Germany e-Clinical Trial Technologies, by Offering USD Million (2017-2022)
  • Table 82. Germany e-Clinical Trial Technologies, by End User USD Million (2017-2022)
  • Table 83. France e-Clinical Trial Technologies, by Phase USD Million (2017-2022)
  • Table 84. France e-Clinical Trial Technologies, by Electronics Solutions USD Million (2017-2022)
  • Table 85. France e-Clinical Trial Technologies, by Offering USD Million (2017-2022)
  • Table 86. France e-Clinical Trial Technologies, by End User USD Million (2017-2022)
  • Table 87. Italy e-Clinical Trial Technologies, by Phase USD Million (2017-2022)
  • Table 88. Italy e-Clinical Trial Technologies, by Electronics Solutions USD Million (2017-2022)
  • Table 89. Italy e-Clinical Trial Technologies, by Offering USD Million (2017-2022)
  • Table 90. Italy e-Clinical Trial Technologies, by End User USD Million (2017-2022)
  • Table 91. United Kingdom e-Clinical Trial Technologies, by Phase USD Million (2017-2022)
  • Table 92. United Kingdom e-Clinical Trial Technologies, by Electronics Solutions USD Million (2017-2022)
  • Table 93. United Kingdom e-Clinical Trial Technologies, by Offering USD Million (2017-2022)
  • Table 94. United Kingdom e-Clinical Trial Technologies, by End User USD Million (2017-2022)
  • Table 95. Netherlands e-Clinical Trial Technologies, by Phase USD Million (2017-2022)
  • Table 96. Netherlands e-Clinical Trial Technologies, by Electronics Solutions USD Million (2017-2022)
  • Table 97. Netherlands e-Clinical Trial Technologies, by Offering USD Million (2017-2022)
  • Table 98. Netherlands e-Clinical Trial Technologies, by End User USD Million (2017-2022)
  • Table 99. Rest of Europe e-Clinical Trial Technologies, by Phase USD Million (2017-2022)
  • Table 100. Rest of Europe e-Clinical Trial Technologies, by Electronics Solutions USD Million (2017-2022)
  • Table 101. Rest of Europe e-Clinical Trial Technologies, by Offering USD Million (2017-2022)
  • Table 102. Rest of Europe e-Clinical Trial Technologies, by End User USD Million (2017-2022)
  • Table 103. MEA e-Clinical Trial Technologies, by Country USD Million (2017-2022)
  • Table 104. MEA e-Clinical Trial Technologies, by Phase USD Million (2017-2022)
  • Table 105. MEA e-Clinical Trial Technologies, by Electronics Solutions USD Million (2017-2022)
  • Table 106. MEA e-Clinical Trial Technologies, by Offering USD Million (2017-2022)
  • Table 107. MEA e-Clinical Trial Technologies, by End User USD Million (2017-2022)
  • Table 108. Middle East e-Clinical Trial Technologies, by Phase USD Million (2017-2022)
  • Table 109. Middle East e-Clinical Trial Technologies, by Electronics Solutions USD Million (2017-2022)
  • Table 110. Middle East e-Clinical Trial Technologies, by Offering USD Million (2017-2022)
  • Table 111. Middle East e-Clinical Trial Technologies, by End User USD Million (2017-2022)
  • Table 112. Africa e-Clinical Trial Technologies, by Phase USD Million (2017-2022)
  • Table 113. Africa e-Clinical Trial Technologies, by Electronics Solutions USD Million (2017-2022)
  • Table 114. Africa e-Clinical Trial Technologies, by Offering USD Million (2017-2022)
  • Table 115. Africa e-Clinical Trial Technologies, by End User USD Million (2017-2022)
  • Table 116. North America e-Clinical Trial Technologies, by Country USD Million (2017-2022)
  • Table 117. North America e-Clinical Trial Technologies, by Phase USD Million (2017-2022)
  • Table 118. North America e-Clinical Trial Technologies, by Electronics Solutions USD Million (2017-2022)
  • Table 119. North America e-Clinical Trial Technologies, by Offering USD Million (2017-2022)
  • Table 120. North America e-Clinical Trial Technologies, by End User USD Million (2017-2022)
  • Table 121. United States e-Clinical Trial Technologies, by Phase USD Million (2017-2022)
  • Table 122. United States e-Clinical Trial Technologies, by Electronics Solutions USD Million (2017-2022)
  • Table 123. United States e-Clinical Trial Technologies, by Offering USD Million (2017-2022)
  • Table 124. United States e-Clinical Trial Technologies, by End User USD Million (2017-2022)
  • Table 125. Canada e-Clinical Trial Technologies, by Phase USD Million (2017-2022)
  • Table 126. Canada e-Clinical Trial Technologies, by Electronics Solutions USD Million (2017-2022)
  • Table 127. Canada e-Clinical Trial Technologies, by Offering USD Million (2017-2022)
  • Table 128. Canada e-Clinical Trial Technologies, by End User USD Million (2017-2022)
  • Table 129. Mexico e-Clinical Trial Technologies, by Phase USD Million (2017-2022)
  • Table 130. Mexico e-Clinical Trial Technologies, by Electronics Solutions USD Million (2017-2022)
  • Table 131. Mexico e-Clinical Trial Technologies, by Offering USD Million (2017-2022)
  • Table 132. Mexico e-Clinical Trial Technologies, by End User USD Million (2017-2022)
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Company Basic Information, Sales Area and Its Competitors
  • Table 147. Company Basic Information, Sales Area and Its Competitors
  • Table 148. Company Basic Information, Sales Area and Its Competitors
  • Table 149. Company Basic Information, Sales Area and Its Competitors
  • Table 150. e-Clinical Trial Technologies: by Phase(USD Million)
  • Table 151. e-Clinical Trial Technologies Phase I , by Region USD Million (2023-2028)
  • Table 152. e-Clinical Trial Technologies Phase II , by Region USD Million (2023-2028)
  • Table 153. e-Clinical Trial Technologies Phase III , by Region USD Million (2023-2028)
  • Table 154. e-Clinical Trial Technologies Phase IV , by Region USD Million (2023-2028)
  • Table 155. e-Clinical Trial Technologies: by Electronics Solutions(USD Million)
  • Table 156. e-Clinical Trial Technologies Clinical Analytics Platforms , by Region USD Million (2023-2028)
  • Table 157. e-Clinical Trial Technologies Electronic Data Capture (EDC) , by Region USD Million (2023-2028)
  • Table 158. e-Clinical Trial Technologies Clinical Data Management Systems (CDMS) , by Region USD Million (2023-2028)
  • Table 159. e-Clinical Trial Technologies Randomization & Trial Supply Management (RTSM) , by Region USD Million (2023-2028)
  • Table 160. e-Clinical Trial Technologies Electronic Clinical Outcome Assessment (ECOA) , by Region USD Million (2023-2028)
  • Table 161. e-Clinical Trial Technologies Clinical Data Integration Platforms , by Region USD Million (2023-2028)
  • Table 162. e-Clinical Trial Technologies Clinical Trial Management Systems (CTMS) , by Region USD Million (2023-2028)
  • Table 163. e-Clinical Trial Technologies Electronic Trial Master File (ETMF) , by Region USD Million (2023-2028)
  • Table 164. e-Clinical Trial Technologies Others , by Region USD Million (2023-2028)
  • Table 165. e-Clinical Trial Technologies: by Offering(USD Million)
  • Table 166. e-Clinical Trial Technologies Solution , by Region USD Million (2023-2028)
  • Table 167. e-Clinical Trial Technologies Services , by Region USD Million (2023-2028)
  • Table 168. e-Clinical Trial Technologies: by End User(USD Million)
  • Table 169. e-Clinical Trial Technologies Research Organizations , by Region USD Million (2023-2028)
  • Table 170. e-Clinical Trial Technologies Pharmaceutical Companies , by Region USD Million (2023-2028)
  • Table 171. e-Clinical Trial Technologies Medical Device Enterprises , by Region USD Million (2023-2028)
  • Table 172. e-Clinical Trial Technologies Others , by Region USD Million (2023-2028)
  • Table 173. South America e-Clinical Trial Technologies, by Country USD Million (2023-2028)
  • Table 174. South America e-Clinical Trial Technologies, by Phase USD Million (2023-2028)
  • Table 175. South America e-Clinical Trial Technologies, by Electronics Solutions USD Million (2023-2028)
  • Table 176. South America e-Clinical Trial Technologies, by Offering USD Million (2023-2028)
  • Table 177. South America e-Clinical Trial Technologies, by End User USD Million (2023-2028)
  • Table 178. Brazil e-Clinical Trial Technologies, by Phase USD Million (2023-2028)
  • Table 179. Brazil e-Clinical Trial Technologies, by Electronics Solutions USD Million (2023-2028)
  • Table 180. Brazil e-Clinical Trial Technologies, by Offering USD Million (2023-2028)
  • Table 181. Brazil e-Clinical Trial Technologies, by End User USD Million (2023-2028)
  • Table 182. Argentina e-Clinical Trial Technologies, by Phase USD Million (2023-2028)
  • Table 183. Argentina e-Clinical Trial Technologies, by Electronics Solutions USD Million (2023-2028)
  • Table 184. Argentina e-Clinical Trial Technologies, by Offering USD Million (2023-2028)
  • Table 185. Argentina e-Clinical Trial Technologies, by End User USD Million (2023-2028)
  • Table 186. Rest of South America e-Clinical Trial Technologies, by Phase USD Million (2023-2028)
  • Table 187. Rest of South America e-Clinical Trial Technologies, by Electronics Solutions USD Million (2023-2028)
  • Table 188. Rest of South America e-Clinical Trial Technologies, by Offering USD Million (2023-2028)
  • Table 189. Rest of South America e-Clinical Trial Technologies, by End User USD Million (2023-2028)
  • Table 190. Asia Pacific e-Clinical Trial Technologies, by Country USD Million (2023-2028)
  • Table 191. Asia Pacific e-Clinical Trial Technologies, by Phase USD Million (2023-2028)
  • Table 192. Asia Pacific e-Clinical Trial Technologies, by Electronics Solutions USD Million (2023-2028)
  • Table 193. Asia Pacific e-Clinical Trial Technologies, by Offering USD Million (2023-2028)
  • Table 194. Asia Pacific e-Clinical Trial Technologies, by End User USD Million (2023-2028)
  • Table 195. China e-Clinical Trial Technologies, by Phase USD Million (2023-2028)
  • Table 196. China e-Clinical Trial Technologies, by Electronics Solutions USD Million (2023-2028)
  • Table 197. China e-Clinical Trial Technologies, by Offering USD Million (2023-2028)
  • Table 198. China e-Clinical Trial Technologies, by End User USD Million (2023-2028)
  • Table 199. Japan e-Clinical Trial Technologies, by Phase USD Million (2023-2028)
  • Table 200. Japan e-Clinical Trial Technologies, by Electronics Solutions USD Million (2023-2028)
  • Table 201. Japan e-Clinical Trial Technologies, by Offering USD Million (2023-2028)
  • Table 202. Japan e-Clinical Trial Technologies, by End User USD Million (2023-2028)
  • Table 203. India e-Clinical Trial Technologies, by Phase USD Million (2023-2028)
  • Table 204. India e-Clinical Trial Technologies, by Electronics Solutions USD Million (2023-2028)
  • Table 205. India e-Clinical Trial Technologies, by Offering USD Million (2023-2028)
  • Table 206. India e-Clinical Trial Technologies, by End User USD Million (2023-2028)
  • Table 207. South Korea e-Clinical Trial Technologies, by Phase USD Million (2023-2028)
  • Table 208. South Korea e-Clinical Trial Technologies, by Electronics Solutions USD Million (2023-2028)
  • Table 209. South Korea e-Clinical Trial Technologies, by Offering USD Million (2023-2028)
  • Table 210. South Korea e-Clinical Trial Technologies, by End User USD Million (2023-2028)
  • Table 211. Southeast Asia e-Clinical Trial Technologies, by Phase USD Million (2023-2028)
  • Table 212. Southeast Asia e-Clinical Trial Technologies, by Electronics Solutions USD Million (2023-2028)
  • Table 213. Southeast Asia e-Clinical Trial Technologies, by Offering USD Million (2023-2028)
  • Table 214. Southeast Asia e-Clinical Trial Technologies, by End User USD Million (2023-2028)
  • Table 215. Australia e-Clinical Trial Technologies, by Phase USD Million (2023-2028)
  • Table 216. Australia e-Clinical Trial Technologies, by Electronics Solutions USD Million (2023-2028)
  • Table 217. Australia e-Clinical Trial Technologies, by Offering USD Million (2023-2028)
  • Table 218. Australia e-Clinical Trial Technologies, by End User USD Million (2023-2028)
  • Table 219. Rest of Asia-Pacific e-Clinical Trial Technologies, by Phase USD Million (2023-2028)
  • Table 220. Rest of Asia-Pacific e-Clinical Trial Technologies, by Electronics Solutions USD Million (2023-2028)
  • Table 221. Rest of Asia-Pacific e-Clinical Trial Technologies, by Offering USD Million (2023-2028)
  • Table 222. Rest of Asia-Pacific e-Clinical Trial Technologies, by End User USD Million (2023-2028)
  • Table 223. Europe e-Clinical Trial Technologies, by Country USD Million (2023-2028)
  • Table 224. Europe e-Clinical Trial Technologies, by Phase USD Million (2023-2028)
  • Table 225. Europe e-Clinical Trial Technologies, by Electronics Solutions USD Million (2023-2028)
  • Table 226. Europe e-Clinical Trial Technologies, by Offering USD Million (2023-2028)
  • Table 227. Europe e-Clinical Trial Technologies, by End User USD Million (2023-2028)
  • Table 228. Germany e-Clinical Trial Technologies, by Phase USD Million (2023-2028)
  • Table 229. Germany e-Clinical Trial Technologies, by Electronics Solutions USD Million (2023-2028)
  • Table 230. Germany e-Clinical Trial Technologies, by Offering USD Million (2023-2028)
  • Table 231. Germany e-Clinical Trial Technologies, by End User USD Million (2023-2028)
  • Table 232. France e-Clinical Trial Technologies, by Phase USD Million (2023-2028)
  • Table 233. France e-Clinical Trial Technologies, by Electronics Solutions USD Million (2023-2028)
  • Table 234. France e-Clinical Trial Technologies, by Offering USD Million (2023-2028)
  • Table 235. France e-Clinical Trial Technologies, by End User USD Million (2023-2028)
  • Table 236. Italy e-Clinical Trial Technologies, by Phase USD Million (2023-2028)
  • Table 237. Italy e-Clinical Trial Technologies, by Electronics Solutions USD Million (2023-2028)
  • Table 238. Italy e-Clinical Trial Technologies, by Offering USD Million (2023-2028)
  • Table 239. Italy e-Clinical Trial Technologies, by End User USD Million (2023-2028)
  • Table 240. United Kingdom e-Clinical Trial Technologies, by Phase USD Million (2023-2028)
  • Table 241. United Kingdom e-Clinical Trial Technologies, by Electronics Solutions USD Million (2023-2028)
  • Table 242. United Kingdom e-Clinical Trial Technologies, by Offering USD Million (2023-2028)
  • Table 243. United Kingdom e-Clinical Trial Technologies, by End User USD Million (2023-2028)
  • Table 244. Netherlands e-Clinical Trial Technologies, by Phase USD Million (2023-2028)
  • Table 245. Netherlands e-Clinical Trial Technologies, by Electronics Solutions USD Million (2023-2028)
  • Table 246. Netherlands e-Clinical Trial Technologies, by Offering USD Million (2023-2028)
  • Table 247. Netherlands e-Clinical Trial Technologies, by End User USD Million (2023-2028)
  • Table 248. Rest of Europe e-Clinical Trial Technologies, by Phase USD Million (2023-2028)
  • Table 249. Rest of Europe e-Clinical Trial Technologies, by Electronics Solutions USD Million (2023-2028)
  • Table 250. Rest of Europe e-Clinical Trial Technologies, by Offering USD Million (2023-2028)
  • Table 251. Rest of Europe e-Clinical Trial Technologies, by End User USD Million (2023-2028)
  • Table 252. MEA e-Clinical Trial Technologies, by Country USD Million (2023-2028)
  • Table 253. MEA e-Clinical Trial Technologies, by Phase USD Million (2023-2028)
  • Table 254. MEA e-Clinical Trial Technologies, by Electronics Solutions USD Million (2023-2028)
  • Table 255. MEA e-Clinical Trial Technologies, by Offering USD Million (2023-2028)
  • Table 256. MEA e-Clinical Trial Technologies, by End User USD Million (2023-2028)
  • Table 257. Middle East e-Clinical Trial Technologies, by Phase USD Million (2023-2028)
  • Table 258. Middle East e-Clinical Trial Technologies, by Electronics Solutions USD Million (2023-2028)
  • Table 259. Middle East e-Clinical Trial Technologies, by Offering USD Million (2023-2028)
  • Table 260. Middle East e-Clinical Trial Technologies, by End User USD Million (2023-2028)
  • Table 261. Africa e-Clinical Trial Technologies, by Phase USD Million (2023-2028)
  • Table 262. Africa e-Clinical Trial Technologies, by Electronics Solutions USD Million (2023-2028)
  • Table 263. Africa e-Clinical Trial Technologies, by Offering USD Million (2023-2028)
  • Table 264. Africa e-Clinical Trial Technologies, by End User USD Million (2023-2028)
  • Table 265. North America e-Clinical Trial Technologies, by Country USD Million (2023-2028)
  • Table 266. North America e-Clinical Trial Technologies, by Phase USD Million (2023-2028)
  • Table 267. North America e-Clinical Trial Technologies, by Electronics Solutions USD Million (2023-2028)
  • Table 268. North America e-Clinical Trial Technologies, by Offering USD Million (2023-2028)
  • Table 269. North America e-Clinical Trial Technologies, by End User USD Million (2023-2028)
  • Table 270. United States e-Clinical Trial Technologies, by Phase USD Million (2023-2028)
  • Table 271. United States e-Clinical Trial Technologies, by Electronics Solutions USD Million (2023-2028)
  • Table 272. United States e-Clinical Trial Technologies, by Offering USD Million (2023-2028)
  • Table 273. United States e-Clinical Trial Technologies, by End User USD Million (2023-2028)
  • Table 274. Canada e-Clinical Trial Technologies, by Phase USD Million (2023-2028)
  • Table 275. Canada e-Clinical Trial Technologies, by Electronics Solutions USD Million (2023-2028)
  • Table 276. Canada e-Clinical Trial Technologies, by Offering USD Million (2023-2028)
  • Table 277. Canada e-Clinical Trial Technologies, by End User USD Million (2023-2028)
  • Table 278. Mexico e-Clinical Trial Technologies, by Phase USD Million (2023-2028)
  • Table 279. Mexico e-Clinical Trial Technologies, by Electronics Solutions USD Million (2023-2028)
  • Table 280. Mexico e-Clinical Trial Technologies, by Offering USD Million (2023-2028)
  • Table 281. Mexico e-Clinical Trial Technologies, by End User USD Million (2023-2028)
  • Table 282. Research Programs/Design for This Report
  • Table 283. Key Data Information from Secondary Sources
  • Table 284. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global e-Clinical Trial Technologies: by Phase USD Million (2017-2022)
  • Figure 5. Global e-Clinical Trial Technologies: by Electronics Solutions USD Million (2017-2022)
  • Figure 6. Global e-Clinical Trial Technologies: by Offering USD Million (2017-2022)
  • Figure 7. Global e-Clinical Trial Technologies: by End User USD Million (2017-2022)
  • Figure 8. South America e-Clinical Trial Technologies Share (%), by Country
  • Figure 9. Asia Pacific e-Clinical Trial Technologies Share (%), by Country
  • Figure 10. Europe e-Clinical Trial Technologies Share (%), by Country
  • Figure 11. MEA e-Clinical Trial Technologies Share (%), by Country
  • Figure 12. North America e-Clinical Trial Technologies Share (%), by Country
  • Figure 13. Global e-Clinical Trial Technologies share by Players 2022 (%)
  • Figure 14. Global e-Clinical Trial Technologies share by Players (Top 3) 2022(%)
  • Figure 15. Global e-Clinical Trial Technologies share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. BioClinica (United States) Revenue, Net Income and Gross profit
  • Figure 18. BioClinica (United States) Revenue: by Geography 2022
  • Figure 19. PAREXEL (United States) Revenue, Net Income and Gross profit
  • Figure 20. PAREXEL (United States) Revenue: by Geography 2022
  • Figure 21. EClinical Solutions (India) Revenue, Net Income and Gross profit
  • Figure 22. EClinical Solutions (India) Revenue: by Geography 2022
  • Figure 23. ECRFPlus (China) Revenue, Net Income and Gross profit
  • Figure 24. ECRFPlus (China) Revenue: by Geography 2022
  • Figure 25. Clincase (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Clincase (Germany) Revenue: by Geography 2022
  • Figure 27. Clinical Leader (United States) Revenue, Net Income and Gross profit
  • Figure 28. Clinical Leader (United States) Revenue: by Geography 2022
  • Figure 29. Oracle (United States) Revenue, Net Income and Gross profit
  • Figure 30. Oracle (United States) Revenue: by Geography 2022
  • Figure 31. Medidata Solutions (United States) Revenue, Net Income and Gross profit
  • Figure 32. Medidata Solutions (United States) Revenue: by Geography 2022
  • Figure 33. Clinpal (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. Clinpal (United Kingdom) Revenue: by Geography 2022
  • Figure 35. NTT DATA (Japan) Revenue, Net Income and Gross profit
  • Figure 36. NTT DATA (Japan) Revenue: by Geography 2022
  • Figure 37. DATATRAK (United States) Revenue, Net Income and Gross profit
  • Figure 38. DATATRAK (United States) Revenue: by Geography 2022
  • Figure 39. OmniComm Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. OmniComm Systems, Inc. (United States) Revenue: by Geography 2022
  • Figure 41. MedNet Solutions (United States) Revenue, Net Income and Gross profit
  • Figure 42. MedNet Solutions (United States) Revenue: by Geography 2022
  • Figure 43. Prelude Dynamics (United States) Revenue, Net Income and Gross profit
  • Figure 44. Prelude Dynamics (United States) Revenue: by Geography 2022
  • Figure 45. Acceliant (United States) Revenue, Net Income and Gross profit
  • Figure 46. Acceliant (United States) Revenue: by Geography 2022
  • Figure 47. Glorant, LLC. (United States) Revenue, Net Income and Gross profit
  • Figure 48. Glorant, LLC. (United States) Revenue: by Geography 2022
  • Figure 49. Medrio, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 50. Medrio, Inc. (United States) Revenue: by Geography 2022
  • Figure 51. Global e-Clinical Trial Technologies: by Phase USD Million (2023-2028)
  • Figure 52. Global e-Clinical Trial Technologies: by Electronics Solutions USD Million (2023-2028)
  • Figure 53. Global e-Clinical Trial Technologies: by Offering USD Million (2023-2028)
  • Figure 54. Global e-Clinical Trial Technologies: by End User USD Million (2023-2028)
  • Figure 55. South America e-Clinical Trial Technologies Share (%), by Country
  • Figure 56. Asia Pacific e-Clinical Trial Technologies Share (%), by Country
  • Figure 57. Europe e-Clinical Trial Technologies Share (%), by Country
  • Figure 58. MEA e-Clinical Trial Technologies Share (%), by Country
  • Figure 59. North America e-Clinical Trial Technologies Share (%), by Country
List of companies from research coverage that are profiled in the study
  • BioClinica (United States)
  • PAREXEL (United States)
  • EClinical Solutions (India)
  • ECRFPlus (China)
  • Clincase (Germany)
  • Clinical Leader (United States)
  • Oracle (United States)
  • Medidata Solutions (United States)
  • Clinpal (United Kingdom)
  • NTT DATA (Japan)
  • DATATRAK (United States)
  • OmniComm Systems, Inc. (United States)
  • MedNet Solutions (United States)
  • Prelude Dynamics (United States)
  • Acceliant (United States)
  • Glorant, LLC. (United States)
  • Medrio, Inc. (United States)
Additional players considered in the study are as follows:
Nextrials (United States) , DSG (United States) , DZS (United States) , Almac (United Kingdom)
Select User Access Type

Key Highlights of Report


Dec 2023 202 Pages 79 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global e-Clinical Trial Technologies Quantitative research analysis
Global e-Clinical Trial Technologies Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in e-Clinical Trial Technologies Market are by end use application [].
The e-Clinical Trial Technologies Market is gaining popularity and expected to see strong valuation by 2028.
  • Rising Costs of Drug Development
  • Increasing Stringent Regulatory Environment Etc.
  • Increasing Challenges in Conducting Clinical Trials for Pharmaceutical Companies
  • Increase Demand for Reducing IT Burden

Know More About Global e-Clinical Trial Technologies Report?

Have a Query? Click Here

Other Related Reports

Natural Language Processing (NLP) in Healthcare Comprehensive Study by Type (Rule-Based NLP, Statistically Based NLP, Mixed NLP), Application (Health Care, Life Science, Other), Organization Size (Sm...
$ 3750
Implantable Drug Delivery Systems Comprehensive Study by Type (Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug-Eluting Stents, Bio-absorbable Stents, Intraocular Stents, Infusion P...
$ 3750
Medical Imaging Technology Comprehensive Study by Application (Orthopedics, Cardiology, Urology, Gastrology, Neurology, Others), Imaging Technology (Radiography, Computed Tomography, Magnetic Resonan...
$ 3650
Healthcare Informatics Comprehensive Study by Type (Nursing Informatics, Pathology Informatics, Imaging Informatics, Pharmacy Informatics, Research Informatics, Others), Application (Hospitals, Speci...
$ 3650
3D Biological Printing Comprehensive Study by Application (Medical (Tissue and Organ Generation, Medical Pills, Prosthetic and Implants, Dental), Biosensors, Consumer/Personal Product Testing, Bioink...
$ 3750
Injectable Bone Substitute Comprehensive Study by Type (Natural Injectable Bone Substitute, Synthetic Injectable Bone Substitute), Application (Hospital, Clinic) Players and Region - Global Market Ou...
$ 3500